Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Capacci

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|November 20, 2009
A facile and practical synthesis of N-acetyl enamidesWenjun Tang, Andrew Capacci, Max Sarvestani, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activatorsBin Ma, Brian Lucas, Andrew Capacci, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
GPR17 structure and agonism with small molecules and oxysterolsClaire M Metrick, Lu Zhang, Maria Hercher, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
Journal of Medicinal Chemistry|May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple SclerosisMartin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|November 20, 2009
A facile and practical synthesis of N-acetyl enamidesWenjun Tang, Andrew Capacci, Max Sarvestani, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activatorsBin Ma, Brian Lucas, Andrew Capacci, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
GPR17 structure and agonism with small molecules and oxysterolsClaire M Metrick, Lu Zhang, Maria Hercher, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
Journal of Medicinal Chemistry|May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple SclerosisMartin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Pageof 1